Quick answer. Latin American markets fall into two groups. In formal-registration markets (most of the region — Mexico, Colombia, Brazil, Argentina, and others), a medical device needs a national sanitary registration held by a locally authorized representative before it can be sold, and that is where an experienced partner adds real value. In a smaller set of import-permit / reliance markets (Belize, Guyana, Suriname, and — for most general devices today — Chile), there is no formal device registration: a licensed local importer clears each shipment on the strength of your quality certificates and reference-country approvals, and you can often arrange it directly. This guide tells you which is which for 21 countries, and what each pathway involves.
bioaccess® acts as a neutral Registration Holder / Authorized Representative across our LATAM coverage, so the registration stays in the manufacturer's name and control — independent of any commercial distributor, who can therefore be appointed and rotated freely.
| Country | Authority | Pathway | Local rep / holder required | Foreign manufacturer can hold? | Reference approval (CE/FDA) | Indicative approval time* |
|---|---|---|---|---|---|---|
| Mexico | COFEPRIS | Formal registration (multi-importer) | Legal rep only | Qualified yes — with a Mexico-resident legal rep | Supports / accelerates (equivalence) | 3–6 months |
| Colombia | INVIMA | Formal registration (multi-importer) | Legal rep only | Yes — foreign holder allowed | Prerequisite | 4–6 months |
| Brazil | ANVISA | Formal registration (single detentor, multiple importers) | Yes | No (local detentor) | Supports (Class III/IV fast-track) | 5–8 months |
| Peru | DIGEMID | Formal registration (multi-importer) | Yes (titular) | No | Prerequisite | 4–6 months |
| Chile | ISP | Light today — most general devices not subject to mandatory registration; per-shipment control document | Importer of record | n/a today | Supports | Weeks (per shipment) |
| Argentina | ANMAT | Formal registration (single AR = importer) | Yes (AAR) | No | Supports / accelerates (Annex I); CE Class II → simplified DDJJ route; FSC is the baseline | 4–7 months |
| Ecuador | ARCSA | Formal registration (single holder) | Yes (local Ecuadorian company) | No | Supports (required only for expedited homologation; FSC suffices for ordinary route) | 4–6 months |
| Costa Rica | Ministry of Health | Formal registration (single holder) | Yes (CRH) | No | Supports | ~6 months |
| Panama | DNFD / MINSA | Formal registration (single-importer rule) | Yes (AR = importer of record) | No | Prerequisite | ~4–6 months |
| Guatemala | MSPAS / DRCPFA | Formal registration (single titular) | Yes | No | Supports | ~5 months |
| Honduras | ARSA | Formal registration (single local legal rep) | Yes | No | Supports | ~5–6 months |
| El Salvador | SRS | Formal registration (single local legal rep) | Yes | No | Supports | ~5–6 months |
| Nicaragua | MINSA / ANRS | Formal registration (held by local importing entity) | Yes | No | Supports | ~5–7 months |
| Dominican Republic | DIGEMAPS | Formal registration (single local AR) | Yes | No | Supports | ~6–8 months |
| Paraguay | DINAVISA | Formal registration (single representative) | Yes | No | Supports | ~5 months |
| Uruguay | MSP | Formal registration (local holder is sole importer) | Yes | No | Supports | ~6 months |
| Bolivia | AGEMED | Formal registration (single local entity) | Yes | No | Supports | ~6 months |
| Venezuela | SACS / MPPS (SIVERC) | Formal registration (single registrant) | Yes | No | Supports | Variable |
| Belize | MoH&W — Drug Inspectorate | Import permit / reliance — no device registration | Licensed local importer | n/a (no registration) | Accepted as evidence | ~1–4 weeks per permit |
| Guyana | GA-FDD | Import permit + importer registration — no device dossier | Licensed local importer | n/a | ISO 13485 + MDSAP + FSC required | Weeks |
| Suriname | Ministerie van Volksgezondheid (Pharmaceutical Inspectorate) | Import permit / reliance — no formal device registry | Licensed local importer | n/a (no registration) | Supports; may be requested for high-risk items | Weeks (scoped per product) |
*Indicative only, after a complete dossier is submitted; agency timelines vary and are outside bioaccess®'s control.
These markets require a national sanitary registration, a local Authorized Representative / Registration Holder, and — as a rule — prior approval in a reference country (CE marking, FDA clearance, or equivalent). This is the work we do: dossier preparation and submission, holding the registration in your name, managing the agency through to approval, and maintaining it (modifications, renewals, vigilance).
Chile (ISP) — a hybrid. Today, most general medical devices fall outside ISP's mandatory-registration list, so each importer pulls its own control document per shipment (closer to the import/reliance model). The pending Ley de Fármacos II will bring more devices into mandatory registration — worth planning for.
Here there is no formal device registration. A locally licensed importer clears each shipment on the strength of your quality certificates and, where applicable, reference-country approval. For these markets we will tell you honestly when you can proceed directly with a local importer, and we assist only where it genuinely helps.
In formal-registration markets, devices are grouped into families by intended use and risk class. Under bioaccess®, one registration covers a whole family — all models, sizes, references, and variants within it — so a line of 200+ implant models does not mean 200 applications. Implants and reusable surgical instruments generally form separate families. In import/reliance markets there is no grouping concept; items are simply listed on the shipment's invoice and permit.
In registration markets, roughly one application per device family per country; we confirm the exact family count from your device list. In import/reliance markets, one importer licence plus per-shipment permits — no per-product filings.
See the table. As a rule: import/reliance markets clear in weeks; formal-registration markets run several months after a complete dossier, with Brazil (ANVISA) and higher-risk classes at the longer end. Reference-country approval (CE/FDA) is a prerequisite in most registration markets and does not, by itself, shorten review except where an equivalence/fast-track applies (e.g., Mexico, Brazil).
Required in essentially every registration market — and it is a core part of what we provide. bioaccess® holds the registration as a neutral Registration Holder / Authorized Representative in your name, so you keep ownership and can appoint and rotate distributors freely, without a distributor holding your market access hostage. In import/reliance markets, a licensed local importer (not a statutory representative) is what's needed.
CE marking is a prerequisite in several registration markets, but not the only accepted basis — many markets also accept FDA clearance or the manufacturer's home-country approval plus ISO 13485 and a Certificate of Free Sale. In the import/reliance markets, non-CE devices can generally still be imported on the strength of your home-country regulatory approval + ISO 13485 + FSC. We confirm the accepted reference basis per country and per product before filing.
All fees are quoted against your actual device list and target countries — the figures below are illustrative ranges, confirmed per engagement (government fees vary and are billed at cost).
Nearly every LATAM registration dossier must be submitted in the destination language — Latin American Spanish in the country variant each regulator reads (es-MX for COFEPRIS, es-AR for ANMAT, and so on) or Brazilian Portuguese for ANVISA — and mistranslated numbers, units, or negations are a real rejection risk. For this, we work with Amavita Sciences™, our specialist LATAM regulatory-translation partner: direct source-to-target translation across 8+ source languages (including Chinese, Japanese, Korean, and German — no English pivot, no two-hop terminology drift) into the variant each of 12 regulators expects, with a signed certificate of accuracy on every file and sworn/juramentada translation routed to a licensed in-country translator only where the filing legally requires it. If your source documents were authored outside Spanish or Portuguese, ask us to loop Amavita in when we scope your dossier.
We prepare and file the dossier, act as your in-country Registration Holder / Legal Representative, manage the agency through to approval, and maintain the registration (modifications, renewals, vigilance) — structured so the registration stays in your name, not a distributor's. And where a market isn't actually regulated, we'll tell you so and point you the right way, rather than sell you a registration you don't need. Full scope and pricing live on our medical device registration and market access page.
Book a 30-minute LATAM market-access call · Importer-of-Record country guide · Regulatory translation — Amavita Sciences™
This guide is for general information and reflects the regulatory position as of 2026; requirements change and the definitive pathway, timeline, and fees for your products are confirmed at scoping. bioaccess® provides regulatory representation, not legal advice.